Literature DB >> 2842346

Hormonal effects of vitamin D3 on epidermal melanocytes.

Z A Abdel-Malek1, R Ross, L Trinkle, V Swope, J W Pike, J J Nordlund.   

Abstract

The role of cholecalciferol, 25(OH) D3, and 1,25(OH)2 D3, as modulators of melanocyte function and proliferation has been examined. Topical application of 100 micrograms cholecalciferol to the pinnal epidermis of DBA/2J mice for 5 or 10 days increased the number of L-dihydroxyphenylalanine-positive (DOPA-positive) melanocytes and had a synergistic effect with a low dose of ultraviolet B light (UVB). Application of 1 microgram 1,25(OH)2 D3 had a transient effect on epidermal melanocytes. Addition of cholecalciferol to pure cultures of human melanocytes did not alter their tyrosinase activity (therefore, melanin synthesis) or growth rate even after 72 hours of treatment. However, treatment of similar cultures with 1,25(OH)2 D3 at a concentration equal to or greater than 10(-8) M suppressed tyrosinase activity but did not affect proliferation. The effect of 25(OH) D3 was similar to, but lower in magnitude than, that of 1,25(OH)2 D3. We attempted to demonstrate the presence of specific receptors for 1,25(OH)2 D3 in normal human melanocytes using the monoclonal antibody (Mo Ab) 9A7 gamma raised against the receptor for 1,25(OH)2 D3. Melanocytes were exposed to 9A7 gamma and to a secondary biotinylated Ab and analyzed by the fluorescence activated cell sorter (FACS). An increase in the specific fluorescent signal was constantly observed. By using the immunoblotting technique, we observed a major immunoreactive species that migrated in the 53-kD region in normal melanocytes. The size of this major immunoreactive species was smaller in melanoma cells than in normal melanocytes. This correlates with the finding that the former cells were unresponsive to cholecalciferol, 25(OH) D3, or 1,25(OH)2 D3 treatment. These results predict a direct role for 1,25(OH)2 D3 as an effector of normal melanocyte function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842346     DOI: 10.1002/jcp.1041360209

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

1.  The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.

Authors:  Joel Pinczewski; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2010-10       Impact factor: 3.960

2.  [Principles of skin pigmentation. Biochemistry and regulation of melanogenesis].

Authors:  M Brenner; C Berking
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

Review 3.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

Review 5.  The protective role of melanin against UV damage in human skin.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Photochem Photobiol       Date:  2008 May-Jun       Impact factor: 3.421

Review 6.  Melanin and lipofuscin as hallmarks of skin aging.

Authors:  Anna Skoczyńska; Elżbieta Budzisz; Ewa Trznadel-Grodzka; Helena Rotsztejn
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837

7.  Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba.

Authors:  Berenice Moreno-Cruz; Bertha Torres-Álvarez; Diana Hernández-Blanco; Juan Pablo Castanedo-Cazares
Journal:  Dermatol Res Pract       Date:  2012-04-22

8.  Vitamin D Receptor Expression in Vitiligo.

Authors:  Reham William Doss; Abdel-Aziz El-Rifaie; Yasser M Gohary; Laila A Rashed
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

9.  Optimization of the method for the culture of melanocyte precursors from hair follicles and their activation by 1,25-dihydroxyvitamin D3.

Authors:  Daguang Wang; Xihui Xu; Huijun Ma; Xuezhuang Yue; Chengrang Li; Wenyuan Zhu
Journal:  Exp Ther Med       Date:  2013-08-06       Impact factor: 2.447

10.  Identification of Genotypes and Allelic Frequencies of Vitamin D Receptor Gene Polymorphism (TaqI) in Egyptian Melasma Patients.

Authors:  Iman Seleit; Ola Ahmed Bakry; Eman Masoud; Shaimaa Nabil
Journal:  Indian Dermatol Online J       Date:  2017 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.